MED28 and colorectal cancer: Therefore, as EG1 is able to inhibit Pax transcription factors, we hypothesized that EG1 could reduce human colorectal cancer cell proliferation due to it having a binding affinity (Kd) of 1.5 μM to the PAX2/PAX5/PAX8 protein DNA binding domain via steady state analysis (22).